Cardiometabolic Health Congress: Bridging the Frontiers of Care

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

CMHC Topics

Our History

First launched in October 2006 in Boston, CMHC has since grown to be the largest US-based, multidisciplinary conference and educational resource addressing cardiometabolic disease prevention and management. Developed, organized, and led by world-renowned clinical authorities across different fields, CMHC has continued to expand its educational offerings, establishing the annual CMHC West: Advancing Cardiometabolic Health from East to West in 2016, launching the highly acclaimed Cardiometabolic Chronicle in 2018, and continually developing a comprehensive online education center for active clinicians.

CMHC Attendee Breakdown

The Cardiometabolic Health Congress is produced by Tarsus®. The acquisition of the CMHC in early 2014 expanded Tarsus' medical division, Tarsus Medical Group, to include live and online medical education offerings focused on the prevention and management of cardiometabolic diseases. Tarsus Medical Group provides a comprehensive, revolutionary collection of global events focused on valuable live and online medical education programs for healthcare practitioners of various specialties. All entities are geared at providing clinical education focused on disease prevention and management, taking into account a rapidly changing health industry.

References:

  1. “Diabetes facts & figures.” International Diabetes Federation, available at https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html, accessed February 18, 2020.
  2. “Obesity and overweight.” World Health Organization, available at https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight, accessed February 18, 2020.
  3. “Raised cholesterol.” World Health Organization, available at https://www.who.int/gho/ncd/risk_factors/cholesterol_prevalence/en/, accessed February 18, 2020.
  4. “Hypertension.” Worldwide Health Organization, available at https://www.who.int/news-room/fact-sheets/detail/hypertension, accessed February 18, 2020.